Thursday, 6 August 2026

Indian corporate news, decoded into deal flow

NSE LIVE
NIFTY 50 INDIA VIX
as of
MARKETS
DEAL FLOW
NRB Industrial Bearings Acquires 9.08% Stake… ▲ Mergers & Acquisitions TVS Group Announces Major NBFC Restructuring:… ▲ Mergers & Acquisitions Viviana Power Tech Q1 FY27 Results:… ▲ Order Book UPL Q1 FY27 Results: Profit Returns… ▲ Capex & Future Plan Nucleus Software Launches FinnOne Neo 9.0… ▲ Capex & Future Plan Clean Science and Technology Posts Record… ▲ Results DCM Shriram International Promoter Acquires 30.07… ▲ Shareholding & Insider Moves
Home / Capex & Future Plans / Neuland Laboratories to Enhance Capacities at Bonthapally and Gaddapotharam Units
CX · Capex & Future Plans

Neuland Laboratories to Enhance Capacities at Bonthapally and Gaddapotharam Units

Neuland Laboratories to Enhance Capacities at Bonthapally and Gaddapotharam Units

Neuland Laboratories Limited has announced plans to enhance capacity at two of its manufacturing facilities:

  • Unit 1 – Bonthapally Village: The peptide synthesizer capacity will increase from 0.5 KL to 6.37 KL, with completion targeted by FY27. The project, costing ₹254 crores, will be funded through a mix of borrowings and internal accruals. This multi-product peptide manufacturing block will support the company’s GDS and CMS businesses for development and commercial production.

  • Unit 3 – Gaddapotharam Village: The facility will undergo a 52 KL capacity expansion, raising the total to 373 KL. Scheduled for completion within 15–18 months, this ₹88-crore project will be funded through internal accruals to meet growing customer demands.

  • Total Investment: The combined capital expenditure for both projects amounts to ₹342 crores.

These expansions align with Neuland Laboratories’ long-term growth strategy, ensuring the company can meet increasing market demands effectively.